Key result
Low-dose aspirin (80 mg/day) significantly reduced the occurrence of pregnancy-induced hypertension compared to placebo in primigravidae with a positive roll-over test (0% vs 52.6%; p=0.0004).
Why the study?
Does aspirin 80 mg/day prevent pregnancy-induced hypertension and preeclampsia in primigravidae with a positive roll-over test?
RCT (n=41)
Double-blind
randomized
Does aspirin 80 mg/day prevent pregnancy-induced hypertension and preeclampsia in primigravidae with a positive roll-over test?
Absolute Event Rate: 0% vs 52.6%
p-value: p=0.0004
Low-dose aspirin (80 mg/day) significantly reduces the incidence of pregnancy-induced hypertension and preeclampsia in primigravidae with a positive roll-over test.
No takes yet. Share an insight, caveat, or question.
Supports targeted low-dose aspirin in primigravidae with positive roll-over test; confirms efficacy for preventing pregnancy-induced hypertension in this high-risk group.
Schröcksnadel et al. (2010) conducted an RCT in Pregnancy-induced hypertension and preeclampsia (n=41). Aspirin vs. Placebo was evaluated on Occurrence of pregnancy-induced hypertension (p=0.0004). Low-dose aspirin (80 mg/day) significantly reduced the occurrence of pregnancy-induced hypertension compared to placebo in primigravidae with a positive roll-over test (0% vs 52.6%; p=0.0004).